Promega Flexi™ Cloning System 

Description

• Directional Cloning of Protein-Coding Sequences
• Choose from a variety of initial applications (e.g., bacterial protein, mammalian or cell-free protein expression) and then transfer the insert as required
• Efficient insert transfer means direct use of recombinant clones with minimal time for screening background colonies
• Adaptable to high-throughput formats for large screening projects

¹L5671, L5681: Licensed under U.S. Pat. No. 5,910,628.

²For research use only. Persons wishing to use this product or its derivatives in other fields of use, including without limitation, commercial sale, diagnostics or therapeutics, should contact Promega Corporation for licensing information.

³This product or portions thereof is manufactured under license from Amrad Corporation Limited. For noncommercial research use only. All other uses require a license from Amrad Corporation Limited, Unit 6, 663 Victoria Street, Abbotsford, Victoria 3067, Australia, under U.S. Patent 5,654,176; Australian Patent 607511, Canadian Patent 1338903 and other issued patents.

⁴U.S. Patent 5,391,487.

⁵Licensed under U.S. Patent 5,945,288.

⁶The pF indicates that the vector is a Flexi vector. The letter after pF indicates the position of any expression tags (N = an N-terminal expression tag). The number associated with the vector specifies the type of expression and application. The letters A and K designate the bacterial drug selection for the vector (A = ampicillin and K = kanamycin).